Press releaseGlobe Newswire
Monopar Therapeutics
MNPR · NASDAQ
$74.23+$2.76 (+3.86%)TodayMarket closed ·
Prev close $71.47
Latest news
- Press releaseGlobe Newswire
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
- Press releaseGlobe Newswire
Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
- Press releaseGlobe Newswire
Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team
- Press releaseGlobe Newswire
Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease
- Press releaseGlobe Newswire
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseGlobe Newswire
Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026
- Press releaseGlobe Newswire
Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease
- Press releaseGlobe Newswire
Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
- Press releaseGlobe Newswire
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026
- NewsHillary Remy
The Year-End 2025 Biotech Rally And What It Means For 2026
- NewsAvi Kapoor
This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releasePRNewswire
Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- NewsAvi Kapoor
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
- News
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
- NewsVandana Singh
Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
- NewsHenry Khederian
Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.